Once-daily ropinirole

Requip XL tablets (ropinirole prolonged release) offer a once-daily dosing schedule for the treatment of idiopathic Parkinson's disease in patients already taking ropinirole immediate-release tablets in whom adequate symptomatic control has been established.

Requip XL may be used alone (without levodopa) or in addition to levodopa to control ‘on-off’ fluctuations which might permit a reduction in the total daily dose of levodopa.

Substitution of Requip XL from ropinirole immediate-release tablets should be supervised by appropriate specialists in Parkinson’s disease.

View Requip XL drug record

Further information: GlaxoSmithKline

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Omega-3 supplements withdrawn from secondary prevention use

Omega-3 supplements withdrawn from secondary prevention use

Omega-3 fatty acids can no longer be prescribed to...

MIMS supplement on contraception and HRT

MIMS supplement on contraception and HRT

The December issue of MIMS includes a special supplement...

Drug shortages - live tracker

Drug shortages - live tracker

Added: clonidine.
Use our constantly updated shortages...

Prescribers reassured over metformin contamination

Prescribers reassured over metformin contamination

Trace amounts of the potential carcinogen N-nitrosodimethylamine...